Literature DB >> 29220570

Neuromicrobiology: How Microbes Influence the Brain.

Cesar de la Fuente-Nunez1,2,3,4,5, Beatriz Torres Meneguetti6, Octávio Luiz Franco6,7, Timothy K Lu1,2,3,4,5.   

Abstract

We review here recent discoveries in the exciting new field of neuromicrobiology. This field encompasses the interactions between the microbiome and the central nervous system. The microbiome has a tremendous impact on human health. In particular, the gut microbiota may play a key role in many essential processes in health and disease via the activity of the gut-brain axis, possibly contributing to autism spectrum disorders, Alzheimer's disease, Parkinson's disease, depression, and anxiety disorder. Gut microbes may also be involved in nociception, complex host behaviors, and brain development. Future efforts will be needed to determine whether the observed associations correspond to causative mechanisms, as well as to engineer effective interventions to modulate the effects of the microbiome on the central nervous system.

Entities:  

Keywords:  Neuromicrobiology; gut microbiota; neurological disorders

Mesh:

Year:  2017        PMID: 29220570     DOI: 10.1021/acschemneuro.7b00373

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  16 in total

1.  In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori.

Authors:  Yanqiang Huang; Xudong Hang; Xueqing Jiang; Liping Zeng; Jia Jia; Yong Xie; Fei Li; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders.

Authors:  Joby Pulikkan; Abhijit Maji; Darshan Bharat Dhakan; Rituja Saxena; Binoop Mohan; Milu Maria Anto; Neeti Agarwal; Tony Grace; Vineet K Sharma
Journal:  Microb Ecol       Date:  2018-03-21       Impact factor: 4.552

3.  Mechanisms of Action of Probiotics.

Authors:  Julio Plaza-Diaz; Francisco Javier Ruiz-Ojeda; Mercedes Gil-Campos; Angel Gil
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 4.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

Review 5.  Molecular tools for probing the microbiome.

Authors:  Marcelo Der Torossian Torres; Cesar de la Fuente-Nunez
Journal:  Curr Opin Struct Biol       Date:  2022-08-16       Impact factor: 7.786

6.  A Freeze-Dried Cranberry Powder Consistently Enhances SCFA Production and Lowers Abundance of Opportunistic Pathogens In Vitro.

Authors:  Christina Khoo; Cindy Duysburgh; Massimo Marzorati; Pieter Van den Abbeele; Derek Zhang
Journal:  BioTech (Basel)       Date:  2022-05-06

Review 7.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

8.  Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells.

Authors:  Haitao Yu; Xiuliang Ding; Lijun Shang; Xiangfang Zeng; Hongbin Liu; Ning Li; Shuo Huang; Yuming Wang; Gang Wang; Shuang Cai; Meixia Chen; Crystal L Levesque; Lee J Johnston; Shiyan Qiao
Journal:  Front Cell Infect Microbiol       Date:  2018-07-13       Impact factor: 5.293

Review 9.  Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling.

Authors:  Florencia Andrea Ceppa; Luca Izzo; Lorenzo Sardelli; Ilaria Raimondi; Marta Tunesi; Diego Albani; Carmen Giordano
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

Review 10.  Probiotic engineering strategies for the heterologous production of antimicrobial peptides.

Authors:  Adriana Mejía-Pitta; Esther Broset; Cesar de la Fuente-Nunez
Journal:  Adv Drug Deliv Rev       Date:  2021-07-14       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.